← Leaderboards
Theodore F Logan
Indiana Univ-Purdue Univ At Indianapolis
$4,647
Attributed
$4,647
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.6K · FY2007–08$5K$3.8K$2.5K$1.3K$0
'07
'08
Funding mix
By agency
NIH$4,647 · 3
By mechanism
M01$4,647 · 3
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Patrick J Loehrer$17,498,162
- Mitchell Goldman$10,867,864
- Kenneth P Nephew$7,005,060
- Mark R. Kelley$16,203,613
- Melissa L Fishel$7,092,542
Others in their field
Top investigators on “Metastatic Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Meenhard Herlyn · University Of Pennsylvania$16,697,165
- Eva Hernando · New York University School Of Medicine$14,325,680
- Pawel Kalinski · Roswell Park Cancer Institute Corp$12,751,872
- Jeffrey S Weber · University Of Southern California$12,012,044
- Patrick Hwu · Clinical Sciences$10,231,202
Research focus
Metastatic MelanomaMetastatic Renal Cell CancerCancer PatientDoseCapsicumDrug KineticsPurposeResearch PersonnelResourcesSourceUnited States National Institutes Of HealthVanilloidVascular Endothelial Growth FactorsFundingFutureGrantGrants, ApplicationsGreen Tea (Dietary)BaseBloodInstitutionClinical Trials, Phase IComputer Retrieval Of Information On Scientific Projects DatabaseHuman Subject
Grant awards (3)
PILOT PHASE I STUDY OF DECAFFEINATED GREEN TEA CONCENTRATE AND CAPSICUM VANILLOI$305
M01 · FY2008 · RR · contact PI
PILOT PHASE I STUDY OF DECAFFEINATED GREEN TEA CONCENTRATE AND CAPSICUM VANILLOI$3,594
M01 · FY2007 · RR · contact PI
Trial of Weekly Low Dose Taxotere in pts with metastatic malignant melanoma.$748
M01 · FY2004 · RR